OJ-Bio is showcasing its Xtalline device for the rapid detection of infectious diseases at Medica this week
Xtalline uses biosensors to identify the presence of various diseases in patient samples with the results of the tests being displayed on a mobile phone app or healthcare systems.
OJ-Bio has said that its platform allows the detection of any protein biomarkers and that a lead application for the device is the detection of C-reactive protein (CRP).
CRP is a biomarker of inflammatory disease which has been proposed as an effective control tool in the reduction of the inappropriate prescribing of antibiotics.
Surface acoustic wave chips commonly found in mobile phones are re-purposed by the device into biochips.
Coating the chips with proteins gives them specific responses when coming into contact with samples containing disease biomarkers. When samples are applied to the disposable biochip the target biomarker binds to the specific capture proteins on the chip surface.
An electronic signal is then translated into a test result displayed on a mobile phone app.
As part of the ‘Internet of Things in Healthcare’ section of the Medica Connected Health Forum Dale Athey, chief executive of OJ-Bio, will be providing more details of Xtalline’s technology and its potential on Thursday 19 November.
OJ-Bio will be showcasing the Xtalline in hall F11 on stand 01.